Health | Page 1122 of 1374 | SpiritIndia.com

ADHD :: Daytrana, methylphenidate transdermal system provides individualized ADHD symptom management

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its Attention Deficit Hyperactivity Disorder (ADHD) patch, DAYTRANA tm (methylphenidate transdermal system), has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when the ADHD patch is taken off earlier than the recommended nine hours. The ability to remove the patch earlier than the recommended nine-hour wear time allows physicians the opportunity to manage the potential for late-day side effects, such as lack of appetite or difficulty sleeping. These phase IIIb clinical trial results were reported today at a major scientific and educational meeting of child and adolescent psychiatrists in San Diego, Calif.

Health :: UWM brain research supports drug development from jellyfish protein

With the research support from the University of Wisconsin-Milwaukee, a Wisconsin biotech company has found that a compound from a protein found in jellyfish is neuro-protective and may be effective in treating neurodegenerative diseases.

Breast Cancer :: Chemo drugs for treating breast cancer may cause changes in cognitive function

A new study investigating the effects of chemotherapy on cognitive function in mice has confirmed what many cancer patients receiving treatment have often complained about ? a decline in their memory and other cognitive functions, sometimes characterized as “chemobrain”.

ADHD :: Lisdexamfetamine dimesylate in ADHD phase 3 data presented

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River Pharmaceuticals Inc. (NASDAQ: NRPH) announced today that their investigational ADHD treatment, lisdexamfetamine dimesylate (also known as NRP104 or LDX), yielded a 60 percent improvement in the primary rating scale scores for symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6 to 12 years who received six months of treatment in an open-label phase III study. Results also demonstrated that at 6 months, 95 percent of children taking lisdexamfetamine dimesylate (NRP104/LDX) produced a “much improved” or “very much improved” rating on the Clinical Global Impressions ? Improvement score. These results were presented last weekend at a national meeting of child and adolescent psychiatrists.

Health :: Painful metaphors of workplace bullying

Workplace bullying negatively impacts employees’ physical and mental health, leading to higher company costs including increased employee illness, use of sick days, and medical costs, ultimately affecting productivity. Studies report that 25-30% of employees experience bullying and emotional abuse sometime during their work life.

Psychiatry :: Cognitive decline is often undetected

Many patients over the age of 65 who are hospitalized with an acute illness experience a subtle change in their cognitive ability that often goes undiagnosed, untreated and underreported. As a result, a patient’s ability to make decisions about his or her medical treatment may be negatively impacted.

ADHD :: Many adults with psychiatric disorders may also have undiagnosed ADHD

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that many adults with a depressive disorder, Bipolar Disorder (BPD), or an anxiety disorder may also have undiagnosed Attention-Deficit/Hyperactivity Disorder (ADHD), according to a longitudinal retrospective medical claims analysis presented today at a major medical meeting of child and adolescent psychiatrists.

Pregnancy :: Career women freezing their eggs until they find a right partner

Most women who freeze their eggs for later use to remove the pressure to find Mr Right, and to preserve their fertility would consider using them to become single mothers. A study of patients who have had their eggs frozen at an IVF clinic in New York suggests that 80 per cent would think about having them fertilised with donor sperm if they failed to find a suitable partner.

Health :: Improving the state of hospital emergency rooms with $142 Million – Ontario

The provincial government has devoted $142 million to improving the state of hospital emergency rooms across Ontario. According to Health Minister George Smitherman the three-point plan addresses issues of money for doctors’ salaries, how to make emergency rooms (ERs) more efficient, and how to reduce wait times.

Diabetes :: Sanofi-Aventis’s Acomplia, rimonabant obesity pill may treat type 2 diabetes

A new obesity pill that helps to control blood sugar levels could treat patients with type 2 diabetes, researchers say. They found that the Sanofi-Aventis drug Acomplia, which is also known as rimonabant, also reduced risk factors for heart disease in patients with type 2 diabetes who had not responded to standard treatments.